The ability to peorm PCI procedures using a very small amount of contrast media enables PCI to be offered to more patient groups, notably patients presenting with both coronary aery disease (CAD) and chronic kidney disease (CKD), who are at high risk of suffering contrast-induced nephropathy (CIN) - a life-threatening form of hospital-acquired acute kidney injury (AKI) caused by contrast media toxicity Royal Philips, a global leader in health technology, recently showcased innovations at EuroPCR (May 17-20, Paris, France) that…
